InvestorsHub Logo
Followers 188
Posts 28919
Boards Moderated 1
Alias Born 08/29/2012

Re: None

Friday, 11/03/2017 9:36:53 PM

Friday, November 03, 2017 9:36:53 PM

Post# of 402270
Opioid epidemic named public health emergency – ADFs more important than ever

Dear XXX,

With the recent announcement by the Trump administration to declare the opioid crisis a Public Health Emergency, one thing became inevitably clear last week - The time is now to take every measure available to combat this epidemic. This includes leveraging the use of medications for opioid addiction to confront America's drug overdose crisis.

On the heels of this monumental announcement, there has never been a more opportune time for leaders in Regulatory Affairs, Clinical Operations, Medical Affairs, Government Relations/Policy, Pharmacovigilance, Generic and Specialty Products to convene at the Abuse-Deterrent Formulations Critical Update Forum, taking place December 7th in Philadelphia, PA. Key stakeholders are set to unite to assess the lay of the land and the pending implications for bio/pharma manufacturers. Join expert faculty to discuss data that supports the efficacy of ADFs and their role in controlling the opioid epidemic.

A vast array of leading organizations will drive the timely dialogue, including Center for Lawful Access & Abuse Deterrence, Depomed, Inc., Collegium Pharmaceutical, Egalet, Tufts University, Journal of Pain Research, INC Research/inVentiv Health and many others. Download the brochure and register today!


Kind Regards,

Vivian Juter Frankel
Conference Producer, ADF Critical Update Forum 2017
CBI, a division of UBM Americas

You Can Tell A Man's Character By The Way He Treats Those Who Can Do Nothing For Him

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News